Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Intrauterine lavage therapy
The First People's Hospital of Lianyungang
Intrauterine Adhesions
1 trial -
Ipilimumab
Iovance Biotherapeutics B.V.
Metastatic Melanoma
1 trial -
Irinotecan Hydrochloride Liposome Injection๏ผCarboplatin Injection๏ผSerplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
Isoniazid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kidney Transplant Infection
1 trial -
Ispaghula
IRONWOOD PHARMACEUTICALS INC
Constipation
1 trial -
Ivosidenib,Venetoclax,gilteritinib,Selinexor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML
1 trial -
Ixekizumab+Jueyin Granules
Universal Integrated
Plaque Psoriasis
1 trial -
KL003 cell injection Drug Product
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transfusion-dependent Beta-Thalassemia
1 trial -
LCAR- F33S cells intravenous infusion
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Relapsed/Refractory Multiple Myeloma(MM)
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
LOC387715/HTRA1 genotyping
Hospital Authority, Hong Kong
Age-Related Macular Degeneration
1 trial -
Lactated ringers solution
The First People's Hospital of Lianyungang
Pancreatitis, Chronic
1 trial -
Lactobacillus rhamnosus F-1
Biotech Pharmaceutical Co.,
Allergic Rhinitis
1 trial -
Lactose-free milk formula (Frisolac LF ยฎ)
Hospital Authority, Hong Kong
Acute Gastroenteritis
1 trial -
Lactulose
The First People's Hospital of Lianyungang
Colon Disease
1 trial -
Lang Qingata
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NASH
1 trial -
Latanoprost
The First People's Hospital of Lianyungang
Ocular Hypertension
1 trial -
Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Low dose midazolam
Hospital Authority, Hong Kong
Intubation
1 trial -
Lugol's Solution (1.5%)
Hospital Authority, Hong Kong
Esophageal Squamous Cell Neoplasm
1 trial -
Luo-Fu-Shan Plaster
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Arthritis, Rheumatoid
1 trial -
Luspatercept
The First People's Hospital of Lianyungang
Transfusion-dependent Non-severe Aplastic Anemia
1 trial -
Luvometinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Langerhans Cell Histiocytosis (LCH)
1 trial -
MTBF regimen
The First People's Hospital of Lianyungang
Relapse Leukemia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources